These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

310 related items for PubMed ID: 9028746

  • 1. Olanzapine. A review of its pharmacological properties and therapeutic efficacy in the management of schizophrenia and related psychoses.
    Fulton B, Goa KL.
    Drugs; 1997 Feb; 53(2):281-98. PubMed ID: 9028746
    [Abstract] [Full Text] [Related]

  • 2. Olanzapine: an updated review of its use in the management of schizophrenia.
    Bhana N, Foster RH, Olney R, Plosker GL.
    Drugs; 2001 Feb; 61(1):111-61. PubMed ID: 11217867
    [Abstract] [Full Text] [Related]

  • 3. Quetiapine : A Review of its Use in Schizophrenia.
    Gunasekara NS, Spencer CM.
    CNS Drugs; 1998 Apr; 9(4):325-40. PubMed ID: 27521016
    [Abstract] [Full Text] [Related]

  • 4. Aripiprazole: a review of its use in schizophrenia and schizoaffective disorder.
    Swainston Harrison T, Perry CM.
    Drugs; 2004 Apr; 64(15):1715-36. PubMed ID: 15257633
    [Abstract] [Full Text] [Related]

  • 5. Adverse events related to olanzapine.
    Conley RR, Meltzer HY.
    J Clin Psychiatry; 2000 Apr; 61 Suppl 8():26-9; discussion 30. PubMed ID: 10811240
    [Abstract] [Full Text] [Related]

  • 6. Olanzapine: a new antipsychotic agent with efficacy in the management of schizophrenia.
    Kando JC, Shepski JC, Satterlee W, Patel JK, Reams SG, Green AI.
    Ann Pharmacother; 1997 Nov; 31(11):1325-34. PubMed ID: 9391688
    [Abstract] [Full Text] [Related]

  • 7. Extrapyramidal symptoms and tolerability of olanzapine versus haloperidol in the acute treatment of schizophrenia.
    Tran PV, Dellva MA, Tollefson GD, Beasley CM, Potvin JH, Kiesler GM.
    J Clin Psychiatry; 1997 May; 58(5):205-11. PubMed ID: 9184614
    [Abstract] [Full Text] [Related]

  • 8. Olanzapine versus haloperidol in the treatment of schizophrenia and schizoaffective and schizophreniform disorders: results of an international collaborative trial.
    Tollefson GD, Beasley CM, Tran PV, Street JS, Krueger JA, Tamura RN, Graffeo KA, Thieme ME.
    Am J Psychiatry; 1997 Apr; 154(4):457-65. PubMed ID: 9090331
    [Abstract] [Full Text] [Related]

  • 9. Olanzapine: an atypical antipsychotic for schizophrenia.
    Lund BC, Perry PJ.
    Expert Opin Pharmacother; 2000 Jan; 1(2):305-23. PubMed ID: 11249551
    [Abstract] [Full Text] [Related]

  • 10. Clozapine, olanzapine, risperidone, and haloperidol in the treatment of patients with chronic schizophrenia and schizoaffective disorder.
    Volavka J, Czobor P, Sheitman B, Lindenmayer JP, Citrome L, McEvoy JP, Cooper TB, Chakos M, Lieberman JA.
    Am J Psychiatry; 2002 Feb; 159(2):255-62. PubMed ID: 11823268
    [Abstract] [Full Text] [Related]

  • 11. Changes in glucose and cholesterol levels in patients with schizophrenia treated with typical or atypical antipsychotics.
    Lindenmayer JP, Czobor P, Volavka J, Citrome L, Sheitman B, McEvoy JP, Cooper TB, Chakos M, Lieberman JA.
    Am J Psychiatry; 2003 Feb; 160(2):290-6. PubMed ID: 12562575
    [Abstract] [Full Text] [Related]

  • 12. Olanzapine versus haloperidol in the treatment of schizophrenia and other psychotic disorders: quality of life and clinical outcomes of a randomized clinical trial.
    Revicki DA, Genduso LA, Hamilton SH, Ganoczy D, Beasley CM.
    Qual Life Res; 1999 Aug; 8(5):417-26. PubMed ID: 10474283
    [Abstract] [Full Text] [Related]

  • 13. Use of olanzapine for elderly patients with psychotic disorders: a review.
    Madhusoodanan S, Sinha S, Brenner R, Gupta S, Bogunovic O.
    Ann Clin Psychiatry; 2001 Dec; 13(4):201-13. PubMed ID: 11958362
    [Abstract] [Full Text] [Related]

  • 14. Effects of clozapine, olanzapine, risperidone, and haloperidol on hostility among patients with schizophrenia.
    Citrome L, Volavka J, Czobor P, Sheitman B, Lindenmayer JP, McEvoy J, Cooper TB, Chakos M, Lieberman JA.
    Psychiatr Serv; 2001 Nov; 52(11):1510-4. PubMed ID: 11684748
    [Abstract] [Full Text] [Related]

  • 15. [Clinical efficacy of olanzapine].
    Yui K.
    Nihon Shinkei Seishin Yakurigaku Zasshi; 1999 Jul; 19(3):101-10. PubMed ID: 10495984
    [Abstract] [Full Text] [Related]

  • 16. Olanzapine.
    Hale AS.
    Br J Hosp Med; 1999 Jul; 58(9):442-5. PubMed ID: 9619205
    [Abstract] [Full Text] [Related]

  • 17. Olanzapine: a serotonin-dopamine-receptor antagonist for antipsychotic therapy.
    Bever KA, Perry PJ.
    Am J Health Syst Pharm; 1998 May 15; 55(10):1003-16. PubMed ID: 9606451
    [Abstract] [Full Text] [Related]

  • 18. Effectiveness and cost of olanzapine and haloperidol in the treatment of schizophrenia: a randomized controlled trial.
    Rosenheck R, Perlick D, Bingham S, Liu-Mares W, Collins J, Warren S, Leslie D, Allan E, Campbell EC, Caroff S, Corwin J, Davis L, Douyon R, Dunn L, Evans D, Frecska E, Grabowski J, Graeber D, Herz L, Kwon K, Lawson W, Mena F, Sheikh J, Smelson D, Smith-Gamble V, Department of Veterans Affairs Cooperative Study Group on the Cost-Effectiveness of Olanzapine.
    JAMA; 2003 Nov 26; 290(20):2693-702. PubMed ID: 14645311
    [Abstract] [Full Text] [Related]

  • 19. Objective and subjective efficacy as well as tolerability of olanzapine in the acute treatment of 120 patients with schizophrenia spectrum disorders.
    Lambert M, Holzbach R, Moritz S, Postel N, Krausz M, Naber D.
    Int Clin Psychopharmacol; 2003 Sep 26; 18(5):251-60. PubMed ID: 12920385
    [Abstract] [Full Text] [Related]

  • 20. Dosing the antipsychotic medication olanzapine.
    Nemeroff CB.
    J Clin Psychiatry; 1997 Sep 26; 58 Suppl 10():45-9. PubMed ID: 9265916
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 16.